Literature Citations
1. Novel Indole-Thiazolidinone Conjugates: Design, Synthesis and Whole-cell Phenotypic Evaluation as a Novel Class of Antimicrobial Agents. Abo-Ashour, M.F., W.M. Eldehna, R.F. George, M.M. Abdel-Aziz, M.M. Elaasser, N.M. Abdel Gawad, A. Gupta, S. Bhakta, and S.M. Abou-Seri. European Journal of Medicinal Chemistry, 2018. 160: p. 49-60. PMID[30317025].
[PubMed]. TB_12_2018.
2. N-substituted Piperazinyl sarafloxacin Derivatives: Synthesis and in Vitro Antibacterial Evaluation. Asadipour, A., M.H. Moshafi, L. Khosravani, S. Moghimi, E. Amou, L. Firoozpour, G. Ilbeigi, K. Beiki, E. Soleimani, and A. Foroumadi. DARU Journal of Pharmaceutical Sciences, 2018. 26(2): p. 199-207. PMID[30392156]. PMCID[PMC6279671].
[PubMed]. TB_12_2018.
3. Studies on New Substituted Pyridazinones: Synthesis and Biological Evaluation. Asif, N., A. Singh, S.A. Khan, and A. Husain. Brazilian Journal of Pharmaceutical Sciences, 2018. 54(3). e00040. ISI[000452191000001].
[WOS]. TB_12_2018.
4. Synthesis and Antimycobacterial Activity of (+)-Usnic acid Conjugates. Cirillo, D., E. Borroni, I. Festoso, D. Monti, S. Romeo, D. Mazier, and L. Verotta. Archiv der Pharmazie, 2018. 351(12). e1800177. PMID[30407647].
[PubMed]. TB_12_2018.
5. Antibiotic Mycotoxins from an Endophytic Fusarium acuminatum Isolated from the Medicinal Plant Geum macrophyllum. Clark, T.N., M. Carroll, K. Ellsworth, R. Guerrette, G.A. Robichaud, J.A. Johnson, and C.A. Gray. Natural Product Communications, 2018. 13(10): p. 1301-1304. ISI[000451936600017].
[WOS]. TB_12_2018.
6. 2-Thiophenecarboxylic acid hydrazide Derivatives: Synthesis and Anti-tuberculosis Studies. Fahmi, M.R.G., L. Khumaidah, T.K. Ilmiah, A. Fadlan, and M. Santoso. 12th Joint Conference on Chemistry, 2018. 349(2018). 012039. ISI[000452032100039].
[WOS]. TB_12_2018.
7. Synthesis, Biological Evaluation and Molecular Docking Studies of 6-(4-Nitrophenoxy)-1H-imidazo[4,5-b]pyridine Derivatives as Novel Antitubercular Agents: Future DprE1 Inhibitors. Gawad, J. and C. Bonde. Chemistry Central Journal, 2018. 12(1): p. 138. PMID[30569203].
[PubMed]. TB_12_2018.
8. The Structures of Benzimidazole Derivatives and Their Potential as Tuberculostatics. Główka, M.L., S. Kałużyńska, M. Krause, K. Gobis, H. Foks, M. Szczesio, and A. Olczak. Acta Crystallographica Section C: Structural Chemistry, 2018. 74(Pt 12): p. 1684-1691. PMID[30569203].
[PubMed]. TB_12_2018.
9. Polysaccharide Rich Extract (PRE) from Tinospora cordifolia Inhibits the Intracellular Survival of Drug Resistant Strains of Mycobacterium tuberculosis in Macrophages by Nitric Oxide Induction. Gupta, P.K. and S. Kulkarni. Tuberculosis, 2018. 113: p. 81-90. PMID[30514517].
[PubMed]. TB_12_2018.
10. Chemical Composition of Acacia farnesiana (L) Wild Fruits and Its Activity against Mycobacterium tuberculosis and Dysentery Bacteria. Hernández-García, E., A. García, E. Garza-González, F.G. Avalos-Alanís, V.M. Rivas-Galindo, J. Rodríguez-Rodríguez, V.M. Alcantar-Rosales, C. Delgadillo-Puga, and M. Del Rayo Camacho-Corona. Journal of Ethnopharmacology, 2019. 230: p. 74-80. PMID[30367988].
[PubMed]. TB_12_2018.
11. Thiazolo[3,2-a] pyrimidones as a Novel anti-TB Agents. Jadhav, S.B., S. Fatema, S.S. Bhagat, and M. Farooqui. Journal of Heterocyclic Chemistry, 2018. 55(12): p. 2893-2900. ISI[000453457300027].
[WOS]. TB_12_2018.
12. Identification and Validation of L-Asparaginase as a Potential Metabolic Target against Mycobacterium tuberculosis. Kataria, A., J. Singh, and B. Kundu. Journal of Cellular Biochemistry, 2019. 120(1): p. 143-154. PMID[30230585].
[PubMed]. TB_12_2018.
13. An Efficient and Facile Green Synthesis of Bisindole methanes as Potential Mtb FtsZ Inhibitors. Khadkikar, P., N.S. Goud, A. Mohammed, G. Ramamoorthy, R. Ananthathatmula, M. Doble, A. Rizvi, S. Banerjee, A. Ravi, and M. Alvala. Chemical Biology & Drug Design, 2018. 92(6): p. 1933-1939. PMID[30003661]. PMCID[PMC6290872].
[PubMed]. TB_12_2018.
14. Prevalence of Nontuberculous Mycobacteria and High Efficacy of D-Cycloserine and Its Synergistic Effect with Clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus. Khosravi, A.D., M. Mirsaeidi, A. Farahani, M.R. Tabandeh, P. Mohajeri, S. Shoja, and S.R. Hoseini Lar KhosroShahi. Infection and Drug Resistance, 2018. 11: p. 2521-2532. PMID[30573983]. PMCID[PMC6290872].
[PubMed]. TB_12_2018.
15. Synergistic Lethality of a Binary Inhibitor of Mycobacterium Tuberculosis KasA. Kumar, P., G.C. Capodagli, D. Awasthi, R. Shrestha, K. Maharaja, P. Sukheja, S.G. Li, D. Inoyama, M. Zimmerman, H.P. Ho Liang, J. Sarathy, M. Mina, G. Rasic, R. Russo, A.L. Perryman, T. Richmann, A. Gupta, E. Singleton, S. Verma, S. Husain, P. Soteropoulos, Z. Wang, R. Morris, G. Porter, G. Agnihotri, P. Salgame, S. Ekins, K.Y. Rhee, N. Connell, V. Dartois, M.B. Neiditch, J.S. Freundlich, and D. Alland. mBio, 2018. 9(6): p. e02101-e02117. PMID[30563908]. PMCID[PMC6299220].
[PubMed]. TB_12_2018.
16. Identification of Novel Benzothiopyranone Compounds against Mycobacterium tuberculosis through Scaffold Morphing from Benzothiazinones. Li, P., B. Wang, X. Zhang, S.M. Batt, G.S. Besra, T. Zhang, C. Ma, D. Zhang, Z. Lin, G. Li, H. Huang, and Y. Lu. European Journal of Medicinal Chemistry, 2018. 160: p. 157-170. PMID[30336450].
[PubMed]. TB_12_2018.
17. Design, Synthesis, Biological Evaluation, Structure-Activity Relationship, and Toxicity of Clinafloxacin-azole Conjugates as Novel Antitubercular Agents. Liu, J., Z. Ren, L. Fan, J. Wei, X. Tang, X. Xu, and D. Yang. Bioorganic & Medicinal Chemistry, 2019. 27(1): p. 175-187. PMID[30522898].
[PubMed]. TB_12_2018.
18. Rational Design of Coumarin Derivatives as Antituberculosis Agents. Mali, H.M., S.S. Sabale, M.S. Degani, R. Borkute, A.S. Choudhari, D. Sarkar, V.S. Krishna, and D. Sriram. Future Medicinal Chemistry, 2018. 10(20): p. 2431-2444. PMID[30325198].
[PubMed]. TB_12_2018.
19. Antimicrobial Activity of Cyathane Derivatives from Cyathus subglobisporus BCC44381. Nitthithanasilp, S., C. Intaraudom, N. Boonyuen, R. Suvannakad, and P. Pittayakhajonwut. Tetrahedron, 2018. 74(48): p. 6907-6916. ISI[000450383600008].
[WOS]. TB_12_2018.
20. Molecular Characterization and Drug Susceptibility of Mycobacterium bovis Isolated from Cattle in Xinjiang, China. Ou, X.C., F. Xu, Y. Zhou, L.L. Tian, Q.Y. Zeng, W.X. Fan, and Y.L. Zhao. Chinese Medical Journal, 2018. 131(24): p. 3017-3019. PMID[30539923].
[PubMed]. TB_12_2018.
21. Antimicrobial and Efflux Inhibitor Activity of Usnic acid against Mycobacterium abscessus. Ramis, I.B., J.S. Vianna, A.J. Reis, A. von Groll, D.F. Ramos, M. Viveiros, and P.E.A. da Silva. Planta Medica, 2018. 84(17): p. 1265-1270. PMID[29913527].
[PubMed]. TB_12_2018.
22. Synthesis, Antituberculosis Studies and Biological Evaluation of New Quinoline Derivatives Carrying 1,2,4-Oxadiazole Moiety. Shruthi, T.G., S. Eswaran, P. Shivarudraiah, S. Narayanan, and S. Subramanian. Bioorganic & Medicinal Chemistry Letters, 2019. 29(1): p. 97-102. PMID[30448235].
[PubMed]. TB_12_2018.
23. Identification of a New Potential Reductase Inhibitor as an Anti-tubercular Agent for Enoyl-Acp Reductase InhA Gene of Mycobacterium tuberculosis in Comparison with PT70 (5-Hexyl-2-(2-methylphenoxy) phenol). Soni, N.K., and C.K. Verma. Indian Journal of Pharmaceutical Education and Research, 2018. 52(4): p. 691-698. ISI[000450531500018].
[WOS]. TB_12_2018.
24. A Novel Derivative of the Fungal Antimicrobial Peptide Plectasin Is Active against Mycobacterium tuberculosis. Tenland, E., N. Krishnan, A. Ronnholm, S. Kalsum, M. Puthia, M. Morgelin, M. Davoudi, M. Otrocka, N. Alaridah, I. Glegola-Madejska, E. Sturegard, A. Schmidtchen, M. Lerm, B.D. Robertson, and G. Godaly. Tuberculosis, 2018. 113: p. 231-238. PMID[30514507]. PMCID[PMC6289163].
[PubMed]. TB_12_2018.
25. Synthesis, Biological Evaluation and Molecular Docking Study of 1,2,3-1H-Triazoles Having 4H-Pyrano[2,3-d]pyrimidine as Potential Mycobacterium tuberculosis Protein Tyrosine phosphatase B Inhibitors. Thanh, N.D., D.S. Hai, N.T.T. Ha, D.T. Tung, C.T. Le, H.T.K. Van, V.N. Toan, D.N. Toan, and L.H. Dang. Bioorganic & Medicinal Chemistry Letters, 2019. 29(2): p. 164-171. PMID[30551903].
[PubMed]. TB_12_2018.
26. Biological Evaluation (Antimicrobial, Antioxidant, and Enzyme Inhibitions), Total Phenolic Content and Volatile Chemical Compositions of Caucasalia macrophylla (M. bieb.) B. nord. (Asteraceae). Yayli, N., S. Fandakli, B. Korkmaz, B. Barut, G. Renda, and I. Erik. Journal of Essential Oil Bearing Plants, 2018. 21(5): p. 1359-1373. ISI[000453234300020].
[WOS]. TB_12_2018.
27. Design, Synthesis, and in Vitro Anti-mycobacterial Activities of 1,2,3-Triazole-tetraethylene Glycol Tethered Isatin Dimers. Zhao, S.J., Z.S. Lv, J.L. Deng, F. Gao, G.D. Zhang, and Z. Xu. Journal of Heterocyclic Chemistry, 2018. 55(12): p. 3006-3010. ISI[000453457300042].
[WOS]. TB_12_2018.
28. Pyrrolidine-containing or Piperazine-containing Nitrofuranylamides: Design, Synthesis, and in Vitro Anti-mycobacterial Activities. Zhao, S.J., Z.S. Lv, J.L. Deng, G.D. Zhang, and Z. Xu. Journal of Heterocyclic Chemistry, 2018. 55(12): p. 2996-3000. ISI[000453457300040].
[WOS]. TB_12_2018.
29. IMB-T130 Targets 3-Dehydroquinate Synthase and Inhibits Mycobacterium tuberculosis. Zhu, N.Y., X. Wang, D.S. Li, Y. Lin, X.F. You, J.D. Jiang, Y.N. Xu, W. Jiang, and S.Y. Si. Scientific Reports, 2018. 8. 17439. PMID[30487577]. PMCID[PMC6262012].
[PubMed]. TB_12_2018.
Patent Citations
30. C5-Substituted Carbapenem Antibiotics, Compositions Containing Such Compounds, and Methods of Use in Treatment of Mycobacterium tuberculosis and Non-tubercular Mycobacteria. Buynak, J.D., N.M.S.A. Al-Kharji, W. Chai, T.Q. Nguyen, M. Alqurafi, K. Rohde, and R. Gupta. Patent. 2018. 2018-16006374 20180353476: 14pp.
[Patent]. TB_12_2018.
31. Tunicamycin Analogues Useful in Treatment of Bacterial Infection, in Particular Tuberculosis. Davis, B.G. Patent. 2018. 2018-GB51539 2018224822: 65pp.
[Patent]. TB_12_2018.